- Home
- TTGT vs SRZN Comparison
TTGT vs SRZN Comparison
Compare TTGT & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTGT | SRZN |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.3M | 271.6M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | TTGT | SRZN |
|---|---|---|
| Price | $3.76 | $21.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $10.75 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 372.0K | 169.9K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.45 | $75.35 |
| Revenue Next Year | $2.75 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.41 | $8.21 |
| 52 Week High | $9.00 | $35.00 |
Technical Indicators
Market Signals| Indicator | TTGT | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 38.58 |
| Support Level | $3.52 | $20.26 |
| Resistance Level | $4.23 | $24.50 |
| Average True Range (ATR) | 0.26 | 1.79 |
| MACD | 0.03 | -0.17 |
| Stochastic Oscillator | 32.09 | 19.32 |
Price Performance
Historical ComparisonAbout TTGT TechTarget Inc.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).